Physician
Psychiatry
Dr. Michael A. Posternak, MD
|
|
Give Review
Michael Posternak practices Psychiatry. He attended Boston University School of Medicine. Boston University School of Medicine has a rank of 30 in research and a 52 in primary care Michael Posternak is a published MD as well. He has 62 publications published. The latest was: Response rates to fluoxetine in subjects who initially show no improvement. He is registered with Medicare.
Publications
- Response rates to fluoxetine in subjects who initially show no improvement.
- A clinically useful depression outcome scale.
- Impact of study design on the results of continuation studies of antidepressants.
- Heterogeneity among depressed outpatients considered to be in remission.
- Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial imp...
- The naturalistic course of unipolar Major depression in the absence of somatic therapy.
- Validity of a self-report depression symptom scale for identifying remission in depressed outpatients.
- How should remission from depression be defined? The depressed patient's perspective.
- Prevalence and features of intermittent explosive Disorder in a clinical setting.
- Differences between minimally depressed patients who do and do not consider themselves to be in remission.
- Empirical testing of two models for staging antidepressant treatment resistance.
- Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial.
- A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive Disorder enrolled in an academic specialty...
- Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study.
- Why isn't bupropion the most frequently prescribed antidepressant?
- Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression?
- Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?
- Tachyphylaxis in unipolar major depressive Disorder.
- Is there a delay in the antidepressant effect? A meta-analysis.
- Elevated rates of psychosis among treatment-seeking Hispanic patients with Major depression.
- Standardized clinical outcome rating scale for depression for use in clinical practice.
- Using a self-report depression scale to identify remission in depressed outpatients.
- Using questionnaires to screen for psychiatric Disorders: a comment on a study of screening for bipolar Disorder in the community.
- Assessing past treatment history: test-retest reliability of the Treatment Response to Antidepressant Questionnaire.
- Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included.
- Defining remission on the Montgomery-Asberg depression rating scale.
- Generalizability of antidepressant efficacy trials.
- Unipolar mania over the course of a 20-year follow-up study.
- How many subjects with major depressive Disorder meet eligibility requirements of an antidepressant efficacy trial?
- Biological markers of atypical depression.
- Symptom severity and exclusion from antidepressant efficacy trials.
- Anger and aggression in psychiatric outpatients.
- The prevalence of atypical features across mood, anxiety, and personality Disorders.
- Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
- Integrating outcomes research into clinical practice.
- A reevaluation of the exclusion criteria used in antidepressant efficacy trials.
- An open-label study of citalopram in the treatment of pathological gambling.
- Partial validation of the atypical features subtype of major depressive Disorder.
- Remission in depressed outpatients: more than just symptom resolution?
- Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive Disorder: a quantitat...
- Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for ...
- Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis.
- Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should...
- How accurate are patients in reporting their antidepressant treatment history?
- Implications of using different cut-offs on symptom severity scales to define remission from depression.
- Lack of association between seasonality and psychopathology in psychiatric outpatients.
- Short-term spontaneous improvement rates in depressed outpatients.
- Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale.
- The effectiveness of switching antidepressants during remission: a case series of depressed patients who experienced intolerable side effects.
- Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients.
- Assessing the risks and benefits of benzodiazepines for anxiety Disorders in patients with a history of substance abuse or dependence.
- Untreated short-term course of Major depression: a meta-analysis of outcomes from studies using wait-list control groups.
- Symptoms of atypical depression.
- An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials.
- A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression.
- A brief assessment of psychosocial functioning of subjects with bipolar I Disorder: the LIFE-RIFT. Longitudinal Interval Follow-up Evaluation-Range Impaired Functionin...
- Which factors influence psychiatrists' selection of antidepressants?
- A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression.
- A pilot effectiveness study: placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant response.
- Predicting recovery from episodes of Major depression.
- Toward achieving optimal response: understanding and managing antidepressant side effects.
Schools
Boston University School Of Medicine
St Elizabeths Hospital
Brown University
Procedures Preformed
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Dysthymia and Cyclothymia (Mood Disorders)
- Major Depressive Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
St Elizabeth's Medical Center -
Boston University School of Medicine
Drug Facts
| NPI NUMBER | 1205811056 | |
| NPPES Provider LastName | POSTERNAK | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 029034923 | |
| NPPES Provider State | RI | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 660.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205811056 |
| Last Name Of The Provider | POSTERNAK |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Leonardo Batista, MD |
|
|
Dr. Wanda S. Needleman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Loreen P. Pirnie |
|
|
Dr. Agnieszka E. Janicka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharath P. Puttichanda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald Neeper, MD |
|
|
Dr. Kristina G. Gaud, MD |
|
|
Dr. Paul H. Shield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela J. Bochiechio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellen V. Kanter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Burgard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul E. Alexander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Agustin G. Yip, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jodi L. Stephenson, MD
This Doctor is OpenDoctor Recommended.
|